Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026)
Jaguar Health's (JAGX) quarterly Change in Accured Expenses came in at $41000.0 in Q1 2026, down 70.92% year-on-year from $141000.0 in Q1 2025, and up 177.36% on a QoQ basis from -$53000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Accured Expenses data on file, last reported at $41000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 70.92% year-over-year to $41000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 228.6% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 281.79% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $41000.0, up from -$53000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for JAGX reached as high as $3.3 million in Q1 2022 and fell as low as -$6.7 million in Q3 2023.
- Historically, Change in Accured Expenses has averaged -$138176.5 across 5 years, with a median of $41000.0 in 2026.
- Across the five-year window, Change in Accured Expenses slumped 5724.0% in 2022 and soared 1017.2% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$1.9 million in 2022, then soared by 125.32% to $473000.0 in 2023, then slumped by 352.85% to -$1.2 million in 2024, then jumped by 95.57% to -$53000.0 in 2025, then soared by 177.36% to $41000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $41000.0 in Q1 2026, -$53000.0 in Q4 2025, and $528000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 931,000.00 |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | -16.82 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 23.10 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 107.70 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | -176.03 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | -16.74 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -309,000.00 |
| Sep 30, 2024 | -309,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Dec 31, 2023 | 473,000.00 |